What Can you Expect at the Personalized Cancer Vaccine Summit 2026?
The 3rd Annual Personalized Cancer Vaccine Summit is the only industry-led forum exclusively focused on all things PCV, from improving antigen selection to fast-tracking vaccine turnaround times, this meeting is designed to advance cancer immunotherapies towards the patients in need.
This niche, intimate forum is uniting leaders in Immunology, Clinical Development, Vaccine Development, R&D, and Immuno-Oncology across a range of vaccine modalities, from mRNA to peptide and dendritic cell platforms, to unlock real-world progress and drive PCVs towards regulatory approval.
For 2026, expect immersive workshops, data-driven presentations, deep dive discussions and dedicated networking opportunities to equip you with the insights, data, and strategies needed for delivering safe, scalable and effective individualized therapies.
Unmissable Event Highlights:
FAST-TRACK
Vaccine production turnaround times by leveraging automation and benchmarking COGS drivers to enhance commercial viability of individualized medicines, with insights from:
DESIGN
Smarter trials by optimizing patient selection strategies and navigating regulatory pathways to accelerate approval of PCVs, with insights from:
LEVERAGE
Clinical data to understand efficacy drivers and inform future vaccine design strategies to optimize clinical success, with insights from:
MASTER
Antigen selection with novel neoantigen prediction models and AI-driven strategies to improve response rates to cancer vaccines, with insights from:
UNCOVER
Next-generation vaccine modalities, from mRNA to dendritic cell, advancing more effective and clinically relevant individualized medicines, with insights from:
What's New for 2026?
New Industry-Leading Speakers
10+ new companies on the speaker faculty, with fresh perspectives from Mayo Clinic, Echo Immune, Diakonos Oncology, City of Hope Comprehensive Cancer Center, Medici Therapeutics, and more, to explore neoantigen prediction strategies, clinical perspectives, manufacturing optimization and safe delivery technologies for translating more efficacious immunotherapies towards approval.
Brand New Data Being Presented
AIVITA Biomedical, SeqCure Immunology, Nykode Therapeutics, YGION Biomedical, HDT Bio, and many others will be sharing never before seen data during in-depth, technical case studies for advancing transformative cancer vaccines towards the patients in need.
Broader Networking Opportunities
More curated networking sessions, including interactive workshop sessions, panel discussions, and speed networking opportunities to enable you to join forces with other individualized therapy experts and collectively discuss challenges of cost, scalability, safety and turnaround times.
Explore The Full 2026 Event Guide
- 20+ expert speakers from pioneering biopharma and leading academics, including Moderna, Medici Therapeutics, Geneos Therapeutics, Nykode Therapeutics, Genentech, HDT Bio, and more
- Gain in-depth data-driven insights into optimizing neoantigen selection, improving clinical trial design and fast-tracking production turnaround times
- 4 interactive workshops and panel discussions to solve challenges in manufacturing, patient selection, clinical development and supply chain costs
Attending Companies Include
Explore the Agenda
Discover the latest breakthroughs shaping personalized cancer vaccine development, from novel target selection strategies, innovative vaccine modalities to clinical and commercial insights. Gain exclusive insights from industry leaders during data-driven presentations, interactive workshops, and expert panel discussions.
Partner With Us
Showcase your solutions alongside other leading service providers to a community dedicated to cutting-edge individualized therapy innovation. Position your brand at the heart of the biopharma deals and partnerships defining oncology immunotherapies.
Join Cancer Vaccine Experts
Connect with cancer vaccine innovators and engage in the hottest conversations propelling safe, efficacious and commercially viable vaccine development. During the dedicated networking sessions, make critical connections, and build meaningful collaborations.